The global competent cells market is expected to achieve a value of USD 3.55 billion in 2026. The emergence of molecular biology, genetic engineering, synthetic biology, and the production of recombinant proteins provides the basis for future growth in the market. The growth of the market will be supported by the growth of research activities in molecular biology, genetic engineering, synthetic biology, and recombinant protein production. Our senior research analyst, Deepa Pandey, has done the analysis of these trends. The findings from this research can aid biotechnology companies, pharmaceutical manufacturers, contract research organizations (CROs), academic and research institutions, suppliers and distributors of laboratory reagents, and investors.
